Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.

NCT00170911 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT00170911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00170911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.
Lead sponsor
Novartis Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2005
Completion date
Not reported
Enrollment
160
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis